Author
S. Paisant
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2023 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 30 mutual co-author links5 papers
Recent·Most cited
- MicrobiologybioRxiv
The host RNA polymerase II C-terminal domain is the anchor for replication of the influenza virus genome
T. Krischuns, B. Arragain, C. Isel…·N. Naffakh
This study shows that host RNA polymerase II's C-terminal domain, along with ANP32, enhances influenza virus polymerase replication activity, suggesting host RNAP II anchors viral transcription and replication.
DOI 10.1038/s41467-024-45205-2 - MicrobiologybioRxivPreprint
The RBPome of influenza A virus mRNA reveals a role for TDP-43 in viral replication
M. Dupont, T. Krischuns, Q. Giai Gianetto…·N. Naffakh
The paper identifies RBPs associated with influenza A virus NP mRNA and shows TDP-43's role in viral replication through mRNA binding and polymerase interactions.
DOI 10.1101/2023.03.21.533609 - MicrobiologybioRxivPreprint
Type B and Type A influenza polymerases have evolved distinct binding interfaces to recruit the RNA polymerase II CTD
T. Krischuns, C. Isel, P. Drncova…·N. Naffakh
This study compares the binding interfaces of influenza B and A polymerases to the host RNA polymerase II CTD, revealing distinct evolutionary adaptations for host range.
- MicrobiologybioRxiv
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
K.-Y. Chen, T. Krischuns, L. Ortega Varga…·N. Naffakh
The paper develops a sensitive cell-based luciferase assay for high-throughput screening of SARS-CoV-2 nsp5/3CLpro inhibitors and identifies four effective compounds.
DOI 10.1016/j.antiviral.2022.105272